🔎 Trials Near Me

Home › Multiple Myeloma › New Jersey › Clifton

Multiple Myeloma clinical trials in Clifton, NJ

15 studies for Multiple Myeloma are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

RecruitingPhase 4
  • Hackensack University Medical Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT05201781

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

RecruitingObservational study
  • Hackensack University Medical Center, Hackensack · 7 mi away
Ages 10 and older · All sexes · Updated Nov 3, 2026 · NCT06323447

Mosaic Trial for Stem Cell Transplant Recipients

Recruiting
  • Hackensack Meridian Health, Nutley · 3 mi away
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06960993

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

RecruitingPhase 1/2
  • Hackensack University Medical Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04973605

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

RecruitingPhase 1
  • Hackensack University Medical Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT05651932

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 1/2
  • Research Site, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07681596

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

RecruitingPhase 3
  • Hackensack Meridian Health, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07648264

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

RecruitingPhase 2
  • John Theurer Cancer Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT04661137

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

RecruitingPhase 1
  • Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT03909412

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

RecruitingPhase 1/2
  • Hackensack University Medical Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06988488

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

RecruitingPhase 1
  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07075185

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

RecruitingPhase 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06121843

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

RecruitingPhase 1
  • Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT05722418

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 1/2
  • John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi away
Ages 18 and older · All sexes · Updated Sep 5, 2025 · NCT05372354

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in Clifton

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.